About Our Research Unit
In 2002, the Stamboulian Group established its Clinical Trials Division — a dedicated unit fully committed to providing comprehensive support services to researchers, contract research organizations (CROs), and sponsors conducting clinical studies in Argentina.
Our research site operates within the framework of Stamboulian Servicios de Salud, one of Argentina's leading health service organizations with over 35 years of experience in infectious disease prevention, vaccination, and laboratory diagnostics. This unique integration provides our clinical trial unit with direct access to an established patient and volunteer base, state-of-the-art laboratory infrastructure, and a multidisciplinary team of infectious disease specialists.
We have successfully conducted more than 50 clinical trials (Phases II, III and IV), enrolling over 2,500 patients and volunteers, with broad experience in antibiotics, antiretrovirals, vaccines, and pharmacokinetics studies, as well as a growing expertise in pediatric research.
Therapeutic Areas
Vaccines
Prophylactic and therapeutic vaccine trials. Extensive experience with Phase II–IV immunogenicity and safety studies.
Antiretrovirals
HIV treatment and prevention studies, including PrEP and novel ARV combinations. Long-standing HIV cohort access.
Antibiotics & Antimicrobials
Experience in community and hospital-acquired infections, including antimicrobial resistance studies.
Pharmacokinetics
PK/PD studies with specialized sampling protocols, centralized processing and rapid turnaround times.
Pediatric Studies
Dedicated infrastructure and experienced team for pediatric clinical research, from neonates to adolescents.
Infectious Diseases (Other)
Respiratory infections, STIs, tropical diseases, emerging pathogens and other infectious disease indications.
Dedicated Research Team
A full support team is assembled for each defined protocol, ensuring operational excellence from study start-up through close-out.
Laboratory Infrastructure
Our central laboratory provides specialized testing services to CROs, pharmaceutical and biotechnology companies in support of clinical trials conducted in Argentina and Latin America. Accredited under IRAM-ISO 15189:2014.
Who We Work With
Pharmaceutical Industry
Global and regional pharma companies seeking experienced investigational sites in Latin America.
NIH & Public Agencies
Government-funded research including NIH-sponsored vaccine and infectious disease studies.
Non-Profit Organizations
NPOs and foundations conducting research in global health, HIV, tropical diseases and vaccines.
Accreditations & Compliance
GCP-ICH Compliant
All studies conducted under International Council for Harmonisation Good Clinical Practice guidelines.
IRAM-ISO 15189:2014
Laboratory accredited under the international standard for medical laboratory quality and competence.
OHRP IRB Registration
Office for Human Research Protections — IRB Registration No. 00001678.
RENIS Code CE000022
Registered in the National Registry for Health Research (RENIS) of the Argentine Ministry of Health.
Buenos Aires MoH Accreditation
Accreditation 031 — Disposition No. 276-DGDOIN/2015, Government of the City of Buenos Aires.
ANMAT Registered
Registered with Argentina's National Administration of Drugs, Foods and Medical Technology (ANMAT).